Form 4 for SLDB Solid Biosciences Inc.

Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-14 · accession 0001209191-22-018885 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-03-15	2022-03-14	SLDB	Morris Carl Ashley	CSO	S - Sale	$1.10	-22.7K	255.2K	-8%	-$24.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-14	S	D	11,269	$1.10	266,605	D	—	—	(F1) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1). (F2) Includes 2,272 shares acquired by Mr. Morris under the Solid Biosciences Employee Stock Purchase Plan on November 30, 2021.
2	Common	Common Stock	2022-03-14	S	D	11,396	$1.10	255,209	D	—	—	(F1) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).